{"title":"RSV Vaccines and RSV Treatments","description":"RSV Vaccines are used to reduce the severity and spread of respiratory syncytial virus (RSV). The Respiratory Syncytial Virus (RSV) is the most common cause of infantile lower respiratory tract infection and a leading cause of childhood hospitalization. RSV Vaccines can be used by adults and children as young as 6 months of age to help reduce their risk of mild to moderate RSV-related respiratory illnesses and, in some cases, more serious RSV infection. As well as, help to reduce the spread of RSV to other people. RSV Vaccine is an important part of keeping our society healthy. Vaccinating your infants, children, and adults is key to preventing the risk of RSV related infection and helping control spread of RSV in infants, children and families.","products":[{"product_id":"rsv-vaccine-rsvpref3-antigen-as01e-pf-respiratory-synctial-virus-vaccine-10-doses-60-year-refrigerated-item","title":"Arexvy RSV Vaccine RSVPreF3 Antigen-AS01E (PF) Respiratory Syncytial Virus Vaccine 10 Doses ** Refrigerated Item","description":"\u003cp\u003eThe RSV Vaccine RSVPreF3 Antigen-AS01E (PF) Respiratory Synctial Virus Vaccine is used to prevent or reduce the severity of respiratory syncytial virus (RSV) infection in individuals who are 60 years of age or older. It works by triggering the body to produce protective antibodies in order to fight the RSV virus. The shots contain a single dose of ovalbumin-based recombinant RSV fusion protein-containing alum-adjuvanted immunogen, a substance that causes the person to create antibodies. Typically, those who are given the vaccine will require two doses of the vaccine each month apart in order to build up immunity and are advised to start the vaccination series six months before RSV season.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of Arexvy RSV Vaccine\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDevelops immunity against the disease-causing Respiratory Syncytial Virus (RSV)\u003c\/li\u003e\n\u003cli\u003eProvides up to 90% reduction of severe disease, including hospitalizations and deaths, caused by RSV, in children\u003c\/li\u003e\n\u003cli\u003eReduces RSV-associated lower respiratory tract disease and bronchiolitis episodes in infants and 1-11 month old infants\u003c\/li\u003e\n\u003cli\u003eHas been proven safe for multiple-dose administration\u003c\/li\u003e\n\u003cli\u003eMay help protect against RSV-associated ear and\/or nose and throat infections\u003c\/li\u003e\n\u003cli\u003eHas been administered to more than 1.2 million infants and children without serious safety concerns\u003c\/li\u003e\n\u003cli\u003eEffective in protecting premature infants from severe RSV disease, while being safe and well tolerated when given to young infants\u003c\/li\u003e\n\u003cli\u003eIs given as a two-stage injection series during RSV season, to babies aged 6 to 24 months in Europe and Asia and older children 9 to 24 months in Latin America\u003c\/li\u003e\n\u003cli\u003eRSV Pre F3 Antigen AS01E (PF) is a subunit recombinant vaccine composed of F and G components, proteins that are intrinsic to the RSV virus strain responsible for causing disease worldwide\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe RSV Vaccine RSVPreF3 Antigen-AS01E (PF) Respiratory Syncytial Virus Vaccine provides immunization and protection against the virus. It's especially important for children six months of age and younger as they are at increased risk for potential respiratory infections from the virus. The RSV Vaccine is created from a single dose of a molecularly-attenuated and purified RSV strain, providing a strong immune response against the virus. After a single dose of the RSV Vaccine, a person should be immunized for approximately one year. The RSV Vaccine 10 dose package provides individuals with full immunization for at least ten years of reliable protection against the virus. Consequently, the RSV Vaccine is a powerful tool in preventing respiratory infections caused by RSV.\u003c\/p\u003e","brand":"GSK Vaccines","offers":[{"title":"Default Title","offer_id":39980199739464,"sku":"58160-0848-11","price":3950.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/RSV-Vaccine-RSVPreF3-Antigen-AS01E-_PF_-Respiratory-Syncytial-Virus-Vaccine-10-Doses.jpg?v=1743429642"},{"product_id":"abrysvo-rsv-vaccine-respiratory-syncytial-virus-vaccine-pfizer-uspg","title":"Abrysvo RSV Vaccine 0.5 mL Kit for RSV by Pfizer USPG 5\/Box (Rx) **Refrigerated","description":"\u003cp\u003eProtect your patients from severe respiratory infections with Abrysvo RSV Vaccine—the advanced, FDA-approved solution for the prevention of Respiratory Syncytial Virus (RSV) in high-risk groups. Trusted worldwide and developed by Pfizer, Abrysvo is your top choice for comprehensive RSV immunization for older adults and pregnant women to safeguard newborns.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003eNote: This product ships signature required. Non-returnable\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Highlights \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad-Spectrum RSV Protection:\u003c\/strong\u003e Prevents severe RSV infection, lower respiratory tract disease, and complications such as pneumonia and bronchiolitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Created by Pfizer USPG, a global leader in vaccine innovation and respiratory disease prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved \u0026amp; CDC Recommended:\u003c\/strong\u003e Meets the highest safety and efficacy standards for RSV vaccination.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Coverage:\u003c\/strong\u003e Indicated for older adults (60+), pregnant women for maternal immunization, and protection for infants during RSV season, following CDC guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Packaging:\u003c\/strong\u003e 5 premeasured 0.5 mL kits per box for easy administration in clinics and hospitals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy Administration:\u003c\/strong\u003e Intramuscular injection designed for efficient workflow in healthcare settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Hospitalizations:\u003c\/strong\u003e Significantly lowers the risk of RSV-related respiratory complications and hospital admissions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health Terms for this product.\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAbrysvo vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory syncytial virus vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePfizer RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for older adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMaternal RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eProtect infants from RSV\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevention of RSV in babies\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSenior vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePregnancy vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory infection prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLower respiratory tract infection vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent RSV pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunization for pregnant women\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for newborn protection\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine side effects\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for high-risk patients\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent bronchiolitis\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBest respiratory vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Abrysvo RSV Vaccine by Pfizer?\u003c\/h3\u003e\n\u003cp\u003eRespiratory Syncytial Virus (RSV) is a major cause of serious respiratory illness in infants, older adults, and those with chronic medical conditions. \u003cem\u003eAbrysvo\u003c\/em\u003e is specially formulated to provide powerful immunity against RSV, reducing the risk of life-threatening complications such as pneumonia and bronchiolitis. \u003cstrong\u003eAbrysvo is especially important for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOlder Adults (Aged 60+):\u003c\/strong\u003e Protect against severe lower respiratory tract disease and reduce RSVP hospital admissions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant Women:\u003c\/strong\u003e Transfer protective antibodies to unborn babies, reducing the risk of RSV infection and hospitalizations in newborns.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh-Risk Individuals:\u003c\/strong\u003e Boost immunity in people with chronic heart or lung disease or weakened immune systems.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWith the seasonality and unpredictability of RSV outbreaks, timely and effective vaccination with Pfizer’s Abrysvo is the gold standard for safeguarding public health.\u003c\/p\u003e\n\u003ch3\u003eUsage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e 0.5 mL per intramuscular injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 5 kits per box, ideal for clinics and healthcare providers\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Single-dose vaccine per CDC and FDA guidelines\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Adults 60+, pregnant women (third trimester) to protect newborns, and those at increased risk for severe RSV disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety Information\u003c\/h3\u003e\n\u003cp\u003eAbrysvo has a strong safety profile with extensive clinical research. The most common side effects are mild and short-lived, such as injection site pain, redness, fatigue, headache, or muscle aches. Severe allergic reactions are extremely rare. Consult a healthcare professional regarding individual health conditions, medical history, and possible interactions.\u003c\/p\u003e\n\u003ch3\u003eOrder Abrysvo RSV Vaccine Today\u003c\/h3\u003e\n\u003cp\u003eStay prepared for RSV season with \u003cstrong\u003eAbrysvo RSV Vaccine 0.5 mL Kit x 5\/Box by Pfizer USPG\u003c\/strong\u003e—the best-in-class solution for comprehensive RSV protection. Stock your practice or healthcare facility to meet CDC and FDA recommendations and protect patients of all ages from serious respiratory complications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Abrysvo now for advanced protection against RSV in adults, pregnant women, and newborns—trusted worldwide for respiratory health and wellness.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":39980445270088,"sku":"00069-0344-05","price":2075.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Abrysvo-RSV-Vaccine-_Respiratory-Syncytial-Virus-Vaccine_-0.5-mL.jpg?v=1756387364"},{"product_id":"abrysvo-rsv-vaccine-respiratory-syncytial-virus-vaccine-0-5-ml-kit-1-kit-refrigerated-item","title":"Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit (Rx) **Refrigerated Item","description":"\u003ch1\u003eAbrysvo (RSV Vaccine) 0.5 mL Injection\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eAbrysvo is a \u003cstrong\u003evaccine\u003c\/strong\u003e made by Pfizer that protects against \u003cstrong\u003erespiratory syncytial virus (RSV)\u003c\/strong\u003e, a common respiratory virus that can cause serious lung infections (lower respiratory tract disease, like bronchitis or pneumonia) in infants and older adults. Abrysvo is a \u003cstrong\u003ebivalent recombinant subunit vaccine\u003c\/strong\u003e – it contains laboratory-made versions of the RSV \u003cstrong\u003efusion (F) protein\u003c\/strong\u003e (from both RSV-A and RSV-B strains) in its “prefusion” stabilized form. When injected, these harmless viral proteins stimulate the immune system to produce antibodies, so the body can fight off RSV if exposed later. Abrysvo does not contain live virus, so it cannot cause RSV.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eWho should get Abrysvo? \u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eAbrysvo has three main indications:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant individuals (32–36 weeks gestation):\u003c\/strong\u003e If given between about 32–36 weeks of pregnancy, Abrysvo protects the newborn against RSV from birth up to 6 months of age. The maternal antibodies cross the placenta to protect the baby after birth. (It is the first RSV vaccine approved for use during pregnancy in the US.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults 60 years and older:\u003c\/strong\u003e A single dose is approved to prevent serious RSV lung disease in seniors. Clinical trials showed Abrysvo reduced the risk of lower respiratory RSV infection in older adults by about 67%..\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults 18–59 at high risk:\u003c\/strong\u003e Adults in this age range who have certain medical conditions (e.g. chronic heart or lung disease, diabetes, immunosuppression, etc.) are also recommended to receive one dose to prevent RSV lung infection.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e(Official use may vary slightly by country’s guidelines. The FDA and EMA approvals match these groups.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage and Administration:\u003c\/strong\u003e Abrysvo is given \u003cstrong\u003eintramuscularly\u003c\/strong\u003e (IM) as a 0.5 mL injection (a single dose) in the upper arm (deltoid). Before injection, the vial is reconstituted (mixed) with a diluent to make the dose. No booster series is currently recommended – just \u003cstrong\u003eone dose per pregnancy\u003c\/strong\u003e (if pregnant) or per RSV season for adults. For pregnant patients, the dose should be administered \u003cstrong\u003ebetween 32 and 36 weeks of gestation\u003c\/strong\u003e (EMA says 24–36 weeks; FDA says 32–36). If an adult misses a season, the vaccine should still be given when possible; it is not given at the same time as yearly flu shots unless coadministration is studied.\u003c\/p\u003e\n\u003cp\u003eBecause Abrysvo is a protein vaccine, it must be handled like other injectables: use a new sterile syringe and needle, inject slowly into muscle, and observe standard vaccine precautions. After injection, monitor the patient for a short time for any immediate reactions.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEffectiveness:\u003c\/strong\u003e Studies have shown that Abrysvo provides strong protection: in seniors, it prevented about two-thirds of RSV lung disease cases; in pregnant women’s babies, it cut RSV illness by about half in the first 6 months of life. (Vaccine-induced antibodies to the RSV prefusion F protein are believed to neutralize the virus on contact.) Protection is expected to last throughout the RSV season (several months).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Most people tolerate Abrysvo well. The \u003cstrong\u003emost frequent side effects\u003c\/strong\u003e (seen in more than 10% of recipients) are mild and short-lived:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection site reactions:\u003c\/strong\u003e pain, redness or swelling where the shot was given.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneral symptoms:\u003c\/strong\u003e fatigue\/tiredness, headache, muscle aches (myalgia), sometimes fever or chills. These usually begin within 1–2 days of vaccination and resolve in a few days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIn pregnant recipients:\u003c\/strong\u003e similar side effects – injection site pain, headache, muscle aches are most common.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Risks:\u003c\/strong\u003e As with any vaccine, serious problems are rare. Key warnings include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergy:\u003c\/strong\u003e Watch for any sign of a severe allergic reaction (hives, swelling of face\/throat, difficulty breathing, dizziness). If this happens (typically within minutes of the shot), emergency treatment is needed. Anaphylaxis has been reported with many vaccines (though it’s very uncommon).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGuillain-Barré Syndrome (GBS):\u003c\/strong\u003e FDA requires a warning that a very small increased risk of GBS (an immune-mediated nerve problem causing weakness) has been observed within about 6 weeks after Abrysvo. The estimated excess is on the order of \u003cstrong\u003e7–9 extra GBS cases per million doses\u003c\/strong\u003e in older adults. The overall evidence suggests a possible association, but it’s still very rare. Patients should be instructed to seek care if they experience unusual weakness or tingling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune-mediated conditions:\u003c\/strong\u003e There have been very few reports of immune reactions (like autoimmune neurologic events) in trials. Patients with a history of the same (e.g. history of GBS) should discuss with their doctor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther:\u003c\/strong\u003e Fever, nausea, or allergic-type symptoms can occur but are uncommon. No new safety signals emerged in trials; about 44,000 people across studies showed mostly mild-moderate reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautions:\u003c\/strong\u003e Abrysvo should not be given to anyone with a known severe allergy to any component of the vaccine (the label suggests none of the excipients are common allergens). If a pregnant person has other routine vaccines due (e.g. Tdap), they can generally be given at separate sites or times (studies showed no interaction). Abrysvo is not a live vaccine, so it can be given safely during pregnancy (unlike some live vaccines). There is a pregnancy registry to monitor outcomes, but to date no safety issues (e.g. birth defects) were found.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e Abrysvo comes in vials that are refrigerated. It should be kept cold until use (often 2–8°C). Once reconstituted, any leftover vaccine should be used promptly and any unused portion discarded (it is preservative-free).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy get Abrysvo?\u003c\/strong\u003e RSV can cause severe illness in young infants (especially preemies) and in older or vulnerable adults. Before Abrysvo, no vaccine existed to prevent RSV. By vaccinating pregnant individuals and high-risk adults, we can reduce hospitalizations and severe disease from RSV. The vaccine does not cause RSV infection; instead, it primes the immune system against it. According to regulators, the benefits of reducing RSV illness outweigh the small risks of side effects.\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":39980447236168,"sku":"00069-0344-01","price":492.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Abrysvo-RSV-Vaccine-_Respiratory-Syncytial-Virus-Vaccine_-0.5-mL_6140b11a-b299-4dfa-a99b-f3c47a9425d9.jpg?v=1692707308"},{"product_id":"synagis-palivizumab-50mg-0-5-ml-single-dose-vial","title":"Synagis palivizumab 50mg\/0.5 mL Single-Dose Vial","description":"\u003cp\u003eSynagis palivizumab 50mg\/0.5 mL Single-Dose Vial is a highly effective medication used for the prevention of serious respiratory tract infections caused by the respiratory syncytial virus (RSV) in infants and children. RSV is a common virus that can lead to severe respiratory infections in young children, particularly those with weakened immune systems. Synagis palivizumab, with its active ingredient 50mg of palivizumab, is administered by injection and works by boosting the child's immunity to fight against RSV. This medication has been proven to reduce the severity and incidence of RSV infections in children, making it an essential tool in pediatric health care. Furthermore, Synagis palivizumab 50mg has been shown to significantly reduce hospitalizations and the need for intensive care in children who are at high risk of contracting RSV. With its ease of administration and minimal side effects, this medication is a crucial component in preventing serious respiratory complications in young children, making it a highly sought-after and beneficial treatment option.\u003c\/p\u003e\n\u003cp\u003eSynagis (palivizumab) is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSynagis 50 mg and 100 mg for injection, is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients:\u003c\/li\u003e\n\u003cli\u003ewith a history of premature birth (≤35 weeks gestational age) and who are 6 months of age or younger at the beginning of RSV season\u003c\/li\u003e\n\u003cli\u003ewith bronchopulmonary dysplasia (BPD) that required medical treatment within the previous 6 months and who are 24 months of age or younger at the beginning of RSV season\u003c\/li\u003e\n\u003cli\u003ewith hemodynamically significant congenital heart disease (CHD) and who are 24 months of age or younger at the beginning of RSV season\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Sobi","offers":[{"title":"Default Title","offer_id":40010860462152,"sku":"66658-0230-01","price":2495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Synagis-palivizumab-50mg-to-protect-against-RSV-infection.jpg?v=1702393826"},{"product_id":"synagis-palivizumab-100mg-1-ml-single-dose-vial","title":"Synagis palivizumab 100mg\/1 mL Single-Dose Vial","description":"\u003cp\u003eSynagis is the only FDA-approved monoclonal antibody to help protect high-risk infants against RSV.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eSynagis palivizumab 100mg\/1 mL Single-Dose Vial is a highly effective medication used to prevent serious respiratory infections in infants and young children caused by the respiratory syncytial virus (RSV). RSV is the most common cause of bronchiolitis and pneumonia in children under the age of one, making it a significant health concern for parents and healthcare providers. Synagis works by targeting the RSV virus and preventing it from replicating, therefore reducing the risk of severe lung infections. This medication has been shown to significantly reduce hospitalizations and even deaths in premature infants and children with lung or heart conditions. Its convenient single-dose vial form makes it easy to administer and its recommended dosage of once a month for a total of 5 doses during RSV season offers excellent protection. The benefits of Synagis palivizumab 100mg are clear, as it not only protects against potentially life-threatening infections, but also provides peace of mind for parents knowing their child is receiving the best prevention possible for RSV.\u003c\/p\u003e\n\u003cp\u003eSynagis (palivizumab) is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSynagis 50 mg and 100 mg for injection, is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients:\u003c\/li\u003e\n\u003cli\u003ewith a history of premature birth (≤35 weeks gestational age) and who are 6 months of age or younger at the beginning of RSV season\u003c\/li\u003e\n\u003cli\u003ewith bronchopulmonary dysplasia (BPD) that required medical treatment within the previous 6 months and who are 24 months of age or younger at the beginning of RSV season\u003c\/li\u003e\n\u003cli\u003ewith hemodynamically significant congenital heart disease (CHD) and who are 24 months of age or younger at the beginning of RSV season\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Sobi","offers":[{"title":"Default Title","offer_id":40010865836104,"sku":"66658-0231-01","price":4900.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Synagis-palivizumab-100mg.jpg?v=1698086065"},{"product_id":"colistimethate-sodium-injection-150-mg-per-vial-rx","title":"Colistimethate Sodium Injection 150 mg Per Vial (RX)","description":"\u003cp\u003eColistimethate injection is an antibiotic medication used for the treatment of severe or life-threatening infections caused by certain types of bacteria. It is commonly used to treat infections caused by multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. These types of infections may occur in people who have weakened immune systems, burn wounds, or cystic fibrosis. Colistimethate injection works by interfering with the growth and reproduction of the bacteria, helping to clear the infection and prevent it from spreading.\u003c\/p\u003e\n\u003cp\u003eColistimethate sodium injection 150 mg per vial is a medication used to treat respiratory tract infections caused by certain bacteria, including Pseudomonas aeruginosa and Acinetobacter baumannii. It belongs to a class of drugs called polymyxins, which work by disrupting the integrity of the bacterial cell membrane, leading to cell death. This injection is usually administered intravenously or intramuscularly by a healthcare professional. It is available in vials containing 150 mg of colistimethate sodium powder for reconstitution.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eColistimethate Sodium Injection 150 mg Per Vial by Avet Pharmaceuticals\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eBenefits of Colistimethate Sodium Injection 150 mg per vial include its ability to treat serious bacterial infections, particularly those caused by multi-drug resistant organisms. It is also considered to have a relatively low toxicity profile and can be administered via intravenous or intramuscular injection, providing flexibility in treatment options. Additionally, its long-acting formulation means that it only needs to be administered once or twice daily, reducing the burden on patients and healthcare providers. Overall, Colistimethate Sodium Injection 150 mg per vial may provide a viable treatment option for infections that are resistant to other antibiotics. \u003c\/p\u003e","brand":"Avet Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293387141192,"sku":"23155-0193-31","price":54.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Colistimethate-Sodium-Injection-150-mg-Per-Vial.jpg?v=1716898880"},{"product_id":"colistimethate-sodium-injection-150-mg-per-vial-12-pack-rx","title":"Colistimethate Sodium Injection 150 mg Per Vial (12-Pack) (RX)","description":"\u003cp\u003eColistimethate sodium is a polymyxin antibiotic designed to treat severe bacterial infections caused by certain gram-negative bacteria, including Pseudomonas aeruginosa. As a prodrug, it is usually administered through injection and can also be used via oral inhalation, especially for patients with cystic fibrosis.\u003c\/p\u003e\n\u003cp\u003eColistimethate injection is an antibiotic medication used for the treatment of severe or life-threatening infections caused by certain types of bacteria. It is commonly used to treat infections caused by multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. These types of infections may occur in people who have weakened immune systems, burn wounds, or cystic fibrosis. Colistimethate injection works by interfering with the growth and reproduction of the bacteria, helping to clear the infection and prevent it from spreading.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey Features \u0026amp; Uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePotent Antibacterial Agent:\u003c\/strong\u003e Specially designed to combat various severe bacterial infections, particularly effective against multidrug-resistant strains in critically ill patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Application:\u003c\/strong\u003e Ideal for treating infections such as pneumonia, urinary tract infections, and septicemia, especially in cases where other antibiotics have failed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDirections \u0026amp; How to Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intravenous injection; consult healthcare professionals for precise dosage and administration tailored to specific medical conditions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e Reconstitute the vial with sterile water as instructed and administer immediately to ensure maximum efficacy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits for Optimal Health:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEffective Infection Control:\u003c\/strong\u003e A robust solution for dealing with life-threatening infections, promoting faster recovery and improved well-being.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMultifunctional Use:\u003c\/strong\u003e Trusted by healthcare providers for its versatility in tackling hard-to-treat infections.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePossible Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e May include reactions like dizziness, headache, or rash. Always monitor and report persistent symptoms to a healthcare provider.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrecautionary Details:\u003c\/strong\u003e Allergic reactions, nephrotoxicity, and neurotoxicity are rare but critical; immediate medical attention is recommended in such cases.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat are Polymyxins?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePolymyxins are a class of antibiotics that are typically used as a last resort treatment for serious infections caused by multidrug-resistant bacteria. They work by disrupting the cell membranes of bacteria, ultimately leading to their death. Polymyxins are only effective against Gram-negative bacteria and are commonly used to treat infections such as pneumonia, sepsis, and urinary tract infections. This class of antibiotics includes the drugs polymyxin B and polymyxin E (also known as colistin). Polymyxins have been in use since the 1950s, but their use has been limited due to their potential for kidney and nerve toxicity.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eStay ahead in health solutions with Colistimethate Sodium Injection, a leading choice for medical experts worldwide. Enhance your defense against challenging infections with this high-demand, top-ranked product.\u003c\/span\u003e\u003c\/p\u003e","brand":"Avet Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40293389434952,"sku":"23155-0193-41","price":339.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Colistimethate-Sodium-Injection-150-mg-Per-Vial_cf6c2226-c4d5-43ed-8399-f3042e38a5e9.jpg?v=1759786868"},{"product_id":"colistimethate-sodium-injection-150-mg-per-vial-by-fresenius-kabi-rx","title":"Colistimethate Sodium Injection 150 mg Per Vial by Fresenius Kabi (RX)","description":"\u003cp\u003eColistimethate injection is an antibiotic medication used for the treatment of severe or life-threatening infections caused by certain types of bacteria. It is commonly used to treat infections caused by multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. These types of infections may occur in people who have weakened immune systems, burn wounds, or cystic fibrosis. Colistimethate injection works by interfering with the growth and reproduction of the bacteria, helping to clear the infection and prevent it from spreading.\u003c\/p\u003e\n\u003cp\u003eColistimethate Sodium Injection 150 mg Per Vial by Fresenius Kabi is a medication used in the treatment of serious bacterial infections, including respiratory tract infections and infections caused by certain types of bacteria that are resistant to other antibiotics. It is a sterile powder that is reconstituted with water for injection and then administered intravenously. It is a type of antibiotic called a polymyxin and works by disrupting the cell walls of bacteria, leading to their death. Fresenius Kabi is the pharmaceutical company that manufactures and sells this medication.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eColistimethate Sodium Injection 150 mg Per Vial by Fresenius Kabi \u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eBenefits of Colistimethate Sodium Injection 150 mg per vial include its ability to treat serious bacterial infections, particularly those caused by multi-drug resistant organisms. It is also considered to have a relatively low toxicity profile and can be administered via intravenous or intramuscular injection, providing flexibility in treatment options. Additionally, its long-acting formulation means that it only needs to be administered once or twice daily, reducing the burden on patients and healthcare providers. Overall, Colistimethate Sodium Injection 150 mg per vial may provide a viable treatment option for infections that are resistant to other antibiotics. \u003c\/p\u003e","brand":"Fresenius Kabi","offers":[{"title":"Default Title","offer_id":40293390417992,"sku":"63323-0393-06","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Colistimethate-Sodium-Injection-150-mg-Per-Vial-by-Fresenius-Kabi.jpg?v=1716900617"},{"product_id":"doxycycline-for-oral-suspension-25-mg-5-ml-strength-60-ml-rx","title":"Doxycycline for Oral Suspension 25 mg\/5 mL Strength 60 mL (RX)","description":"\u003cp\u003eDoxycycline for Oral Suspension 25 mg\/5 mL Strength 60 mL is a prescription medication used to treat various bacterial infections, such as respiratory tract infections, urinary tract infections, and skin infections. It is in the class of antibiotics known as tetracyclines and works by inhibiting the growth and spread of bacteria. This particular strength of Doxycycline for Oral Suspension contains 25 mg of doxycycline per 5 mL of solution, and the bottle contains 60 mL of the suspension. It is usually taken orally, either with or without food, as directed by a doctor.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action for Doxycycline for Oral Suspension 25 mg\/5 mL:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe mechanism of action for Doxycycline for Oral Suspension 25 mg\/5 mL involves inhibiting the growth and spread of bacteria by targeting certain proteins that are essential for their survival. Doxycycline belongs to a class of antibiotics known as tetracyclines, which work by specifically binding to the bacteria's ribosome, a cellular organelle responsible for protein synthesis. This binding prevents the bacteria from producing necessary proteins, ultimately leading to its death. Additionally, Doxycycline also has anti-inflammatory and immunomodulatory effects, further aiding in its antibacterial activity.\u003cbr\u003e\u003c\/p\u003e","brand":"Lupin Pharma","offers":[{"title":"Default Title","offer_id":40327808516168,"sku":"68180-0657-01","price":29.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Doxycycline-Oral-Suspension-25-mg-Lupin-Pharma-68180-0657-01.jpg?v=1764696217"},{"product_id":"prevar-20-pneumococcal-20-valent-conjugate-vaccine-diphtheria-crm197-protein","title":"Prevnar 20 Vaccine Pneumococcal 20-valent Conjugate (Diphtheria CRM197 Protein) 0.5 mL x 10\/Pack Pfizer USPG **Refrigerated (RX)","description":"\u003cp\u003eProtect your patients against 20 strains of invasive pneumococcal disease with Prevnar 20—the latest advancement in pneumococcal immunization from Pfizer. Trusted by healthcare professionals, Prevnar 20 delivers comprehensive, broad-spectrum protection for adults and children, helping prevent pneumonia, bloodstream infections, and meningitis caused by Streptococcus pneumoniae.\u003c\/p\u003e\n\u003ch3\u003eProduct Features \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroadest Pneumococcal Coverage:\u003c\/strong\u003e The only FDA-approved 20-valent conjugate vaccine, targeting 20 pneumococcal serotypes responsible for the majority of invasive infections.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvanced Conjugate Technology:\u003c\/strong\u003e Utilizes Diphtheria CRM197 protein carrier to stimulate a strong, lasting immune response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Developed by Pfizer USPG, a global leader in vaccines and infection prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Indications:\u003c\/strong\u003e Approved for use in adults 18+ and pediatric patients as indicated by the CDC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use Dosing:\u003c\/strong\u003e Available in convenient, single-dose prefilled syringes for easy administration in hospitals, clinics, and long-term care settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC and ACIP Recommended:\u003c\/strong\u003e Aligned with current immunization guidelines for adult and childhood pneumococcal vaccination schedules.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health-Related Searched Terms:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003ePrevnar 20 vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumococcal conjugate vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e20-valent pneumonia vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumonia prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdult immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSenior vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eChildhood vaccination\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumonia vaccine for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePfizer vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccines for seniors over 65\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunization for chronic disease\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory infection prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTravel vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevention of bacterial pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumococcal disease protection\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLong-term care vaccination\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Prevnar 20?\u003c\/h3\u003e\n\u003cp\u003ePneumococcal infections are a leading cause of morbidity and mortality, especially in adults over 65, those with chronic diseases, and young children. \u003cstrong\u003ePrevnar 20\u003c\/strong\u003e offers the highest valency available in pneumococcal conjugate vaccines, increasing immunity against more serotypes than ever before.\u003c\/p\u003e\n\u003cp\u003eWhether you’re aiming to fulfill the \u003cstrong\u003eadult or senior pneumonia vaccine recommendations\u003c\/strong\u003e, protect high-risk populations from invasive \u003cem\u003eStreptococcus pneumoniae\u003c\/em\u003e infections, or support robust immunity in pediatric and immunocompromised patients, \u003cstrong\u003ePrevnar 20 by Pfizer\u003c\/strong\u003e sets a new standard for preventive healthcare.\u003c\/p\u003e\n\u003ch3\u003eAdministration \u0026amp; Dosage\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e 0.5 mL intramuscular injection (single-dose vial or prefilled syringe)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAge Indication:\u003c\/strong\u003e Adults 18 years and older; children per CDC guidelines\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing Schedule:\u003c\/strong\u003e Single-dose for most adults; consult CDC guidelines for pediatric series or catch-up immunizations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety \u0026amp; Side Effects\u003c\/h3\u003e\n\u003cp\u003ePrevnar 20 is well-tolerated, with side effects usually mild to moderate and transient. The most common include injection site pain, redness, swelling, muscle aches, fatigue, headache, and mild fever. Serious allergic reactions are rare. Consult a healthcare provider regarding medical history and potential contraindications.\u003c\/p\u003e\n\u003ch3\u003eOrder Prevnar 20 Vaccine Today\u003c\/h3\u003e\n\u003cp\u003eEnhance your immunization program with \u003cstrong\u003ePrevnar 20 Pneumococcal 20-valent Conjugate Vaccine by Pfizer USPG\u003c\/strong\u003e—the most comprehensive pneumococcal vaccine available. Stock up and protect adults and children against the full spectrum of serious pneumococcal diseases.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Prevnar 20 now for broad-spectrum protection, effective pneumonia prevention, and the latest in vaccine technology—trusted for adult, senior, and pediatric immunization worldwide.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":40352071778376,"sku":"00005-2000-10","price":3650.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Prevnar-20-Vaccine-Pneumococcal-20-valent-Conjugate-Diphtheria-CRM197-Protein.jpg?v=1756384486"},{"product_id":"ribavirin-tablets-200-mg-by-aurobindo","title":"Ribavirin Tablets 200 mg by Aurobindo 168 Count (RX)","description":"\u003cp\u003eRibavirin Tablets 200 mg are an antiviral medication used in combination with other medications to treat chronic hepatitis C infection. It works by stopping the virus from multiplying and infecting new cells in the body. This medication may also be used to treat severe respiratory syncytial virus (RSV) infection in children. It should always be used under the guidance of a healthcare professional.\u003c\/p\u003e\n\u003cp\u003eRibavirin Tablets 200 mg are a prescription medication used in the treatment of hepatitis C virus, a liver infection. They contain the active ingredient ribavirin, which works by stopping the virus from multiplying and spreading in the body.\u003c\/p\u003e\n\u003cp\u003eThese tablets are typically used in combination with other medications, such as interferon or sofosbuvir, to increase the success rate of treatment. Together, these drugs work to eradicate the hepatitis C virus from the body, preventing it from causing liver damage and other complications.\u003c\/p\u003e\n\u003cp\u003eRibavirin Tablets 200 mg are available in both brand-name and generic forms, and they are only available with a doctor's prescription. They should be taken exactly as directed by a healthcare provider, and treatment often lasts for several weeks or months depending on the specific treatment plan. \u003c\/p\u003e\n\u003c!----\u003e","brand":"Aurobindo Pharma USA","offers":[{"title":"Default Title","offer_id":40373345189960,"sku":"65862-0207-68","price":179.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ribavirin-Tablets-200-mg-by-Aurobindo-168-Count-by-Aurobindo-Pharma.jpg?v=1724692296"},{"product_id":"abrysvo-rsv-vaccine-respiratory-syncytial-virus-act-o-vial-0-5-ml-1-dose-pfizer-uspg","title":"Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Pfizer USPG **Refrigerated (RX)","description":"\u003cp\u003eDefend against Respiratory Syncytial Virus (RSV) with the Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG—the breakthrough, FDA-approved RSV vaccine for adults and maternal immunization. As recommended by the CDC, Abrysvo delivers advanced protection to high-risk populations, including adults 60+, pregnant women, and individuals with chronic health conditions.\u003c\/p\u003e\n\u003ch3\u003eProduct Highlights \u0026amp; Top Health Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplete RSV Protection:\u003c\/strong\u003e Guards adults, seniors, and pregnant women against severe RSV infection, RSV pneumonia, and RSV-related bronchiolitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose Act-O-Vial:\u003c\/strong\u003e Convenient 0.5 mL intramuscular injection, ideal for clinics, hospitals, and healthcare providers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePfizer Quality:\u003c\/strong\u003e Developed by Pfizer USPG, a world leader in vaccines and infectious disease prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA Approved \u0026amp; CDC Recommended:\u003c\/strong\u003e Robust clinical studies support its efficacy and safety for respiratory syncytial virus immunization.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaternal RSV Immunization:\u003c\/strong\u003e Protects newborns through passive immunity by vaccinating expectant mothers during pregnancy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSenior \u0026amp; High-Risk Vaccination:\u003c\/strong\u003e Designed for adults aged 60 and above, as well as those with underlying conditions such as heart or lung disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Hospitalizations:\u003c\/strong\u003e Minimizes the risk of hospital visits and severe outcomes due to RSV.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health terms for this Product:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAbrysvo RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccination for seniors\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory syncytial virus vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePfizer RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine side effects\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMaternal RSV immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBest RSV vaccine for pregnancy\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV shot for elderly\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent RSV in infants\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV immunization schedule\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSingle dose RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAct-O-Vial RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eProtection from RSV pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for bronchiolitis prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdult respiratory vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePregnancy vaccines for RSV\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHigh-risk respiratory immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRSV is a leading cause of lower respiratory infections, pneumonia, and hospitalizations among adults 60 and older, people with chronic health conditions, and newborns via maternal transmission.\u003c\/strong\u003e The Abrysvo RSV Vaccine Act-O-Vial is formulated to deliver advanced, season-long protection. By choosing Abrysvo, you’re selecting:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCutting-edge RSV prevention\u003c\/strong\u003e for seniors, adults, and expecting mothers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaternal vaccine protection\u003c\/strong\u003e that safeguards both mother and baby from severe RSV.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConfidence in vaccination\u003c\/strong\u003e with Pfizer’s proven safety, quality, and worldwide trust.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlignment with the latest CDC and FDA RSV vaccine guidelines\u003c\/strong\u003e for high-risk patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDirections for Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e 0.5 mL Act-O-Vial, single intramuscular dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Adults 60+, pregnant women for maternal antibody transfer, and other at-risk individuals as per CDC and FDA guidance\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e By healthcare professional in clinics, hospitals, or physician’s offices\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerate; do not freeze.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety \u0026amp; Side Effects\u003c\/h3\u003e\n\u003cp\u003eThe Abrysvo RSV vaccine is well-tolerated and extensively tested. The most common side effects include mild injection site pain, fatigue, headache, and slight swelling—serious reactions are exceedingly rare. Always consult your healthcare provider before vaccination, especially regarding allergies or prior vaccine reactions.\u003c\/p\u003e\n\u003ch3\u003eOrder Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Today\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eStay protected this RSV season.\u003c\/strong\u003e The Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG is the leading choice for comprehensive RSV immunization in seniors, adults, high-risk groups, and pregnant women seeking to protect their infants. Make Abrysvo part of your immunization program and meet CDC vaccine requirements with confidence.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Abrysvo RSV Vaccine today for industry-leading, FDA-approved protection against the risks of RSV pneumonia, bronchiolitis, and respiratory complications. Trust Pfizer—the name in respiratory health.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":52510764433776,"sku":"00069-2465-01","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Abrysvo-RSV-Vaccine-for-Respiratory-Syncytial-Virus-Act-O-Vial-Pfizer.jpg?v=1756387983"}],"url":"https:\/\/www.mountainside-medical.com\/collections\/rsv-vaccines\/rsv-vaccine+antigen.oembed","provider":"Mountainside Medical","version":"1.0","type":"link"}